Thomas Civik - 24 Mar 2023 Form 4 Insider Report for Pyxis Oncology, Inc. (PYXS)

Role
Director
Signature
/s/ Pamela Connealy, Attorney-in-Fact for Thomas Civik
Issuer symbol
PYXS
Transactions as of
24 Mar 2023
Net transactions value
$0
Form type
4
Filing time
28 Mar 2023, 16:41:02 UTC
Previous filing
16 May 2022
Next filing
12 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PYXS Common Stock Award $0 +139,355 +209% $0.000000 206,186 24 Mar 2023 Direct F1
holding PYXS Common Stock 15,700 24 Mar 2023 By Civik Family Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.
F2 These shares are held directly by the Civik Family Trust, a revocable trust for which the Reporting Person and his spouse are the grantors.